CoChat

Mendelian randomization suggests non‐causal associations of testosterone with cardiometabolic risk factors and mortality

Open access
Haring, R., Teumer, A., Völker, U., Dörr, M., Nauck, M., Biffar, R., Völzke, H., Baumeister, S. E., Wallaschofski, H. · 2013 · Andrology
Cited by 55

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Summary: Prospective studies showed that low serum testosterone concentrations are associated with various cardiometabolic risk factors and mortality. However, the causal nature of these associations is controversial. We studied 1 882 men aged 20–79 years with serum testosterone concentrations and genotyping data from the longitudinal population‐based Study of Health in Pomerania. Testosterone concentrations were cross‐sectionally associated with cardiometabolic risk factors, including anthropometric, lipid, blood pressure and glycaemic parameters; and prospectively with all‐cause mortality (277 deaths, 14.7%) during the 10‐year follow‐up. To overcome problems of residual confounding, reverse causation, or regression dilution bias in the investigated testosterone‐outcome associations, we used two‐stage least square regression models with previously identified polymorphisms at the SHBG gene (rs12150660) and X chromosome (rs5934505) as multiple genetic instruments in an instrumental variable (IV) approach, also known as Mendelian randomization. In standard regression analyses, testosterone was robustly associated with a wide range of cardiometabolic risk factors. In subsequent IV analyses, no such significant associations were observed. Similarly, prospective analyses showed a consistent association of low testosterone concentrations with increased all‐cause mortality risk, which was not apparent in subsequent IV analyses. The present Mendelian randomization analyses did not detect any evidence for causal associations of testosterone concentrations with cardiometabolic risk factors and mortality, suggesting that previously reported associations might largely result from residual confounding or reverse causation. Although testosterone assessment might improve risk prediction, implementation of testosterone replacement therapy requires further evidence of a direct effect on cardiometabolic outcomes from double‐blinded randomized controlled trials and large‐scale Mendelian randomization meta‐analyses.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.2047-2927.2012.00002.x

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 55

Metadata

Authors
Haring, R., Teumer, A., Völker, U., Dörr, M., Nauck, M., Biffar, R., Völzke, H., Baumeister, S. E., & Wallaschofski, H.
Venue
Andrology
Publisher
Wiley
Published
2012-08-26
Volume
1
Issue
1
Pages
17-23
ISSN
  • 2047-2919 (ISSN-L)
  • 2047-2927
OpenAlex
W2001071180
Cited by
55
References
14
FWCI
4.60
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mendelian randomization suggests non‐causal associations of testosterone with cardiometabolic risk factors and mortality. https://app.cochat.ai/papers/10.1111/j.2047-2927.2012.00002.x
The paper
Haring, R., Teumer, A., Völker, U., Dörr, M., Nauck, M., Biffar, R., Völzke, H., Baumeister, S. E., & Wallaschofski, H. (2013). Mendelian randomization suggests non‐causal associations of testosterone with cardiometabolic risk factors and mortality. Andrology. https://doi.org/10.1111/j.2047-2927.2012.00002.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.